High selective antileishmanial activity of vanadium complex with stilbene derivative

Acta Tropica

Volumn 148, Issue , 2015, Pages 120-127

  Machado, Patrícia de Almeida ^a   Mota, Vinícius Zamprogno ^a   Cavalli, Ana Clara de Lima ^a   de Carvalho, Gustavo Senra Gonçalves ^a   Da Silva, Adilson David ^a   Gameiro, Jacy ^a   Cuin, Alexandre ^a   Coimbra, Elaine Soares ^a  

^a FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

Author keywords

Leishmania amazonensis; Mitochondrial dysfunction; Nitric oxide; Stilbenes; Vanadium complex

Indexed keywords

4 NITROBENZALDEHYDE; ACETAMINOSALOL; AMPHOTERICIN B; ANTILEISHMANIAL AGENT; ANYSALDEHYDE; BENZALDEHYDE; MILTEFOSINE; ORGANIC COMPOUND; ORTHO VANILLIN; OXOVANADIUM ACETAMINOSALOL; REACTIVE OXYGEN METABOLITE; SALYCILALDEHYDE; UNCLASSIFIED DRUG; VANADIUM DERIVATIVE; VANILLIN; ANTIPROTOZOAL AGENT; SALICYLIC ACID DERIVATIVE;

BIOASSAY; CONCENTRATION (COMPOSITION); DISEASE TREATMENT; LEISHMANIASIS; MITOCHONDRION; NITRIC OXIDE; TOXICITY;

AMASTIGOTE; ANIMAL CELL; ANTIPROTOZOAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY ASSAY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG CYTOTOXICITY; DRUG DETERMINATION; DRUG EFFECT; DRUG SCREENING; DRUG SELECTIVITY; DRUG SYNTHESIS; ERYTHROCYTE; HUMAN; HUMAN CELL; IC50; LEISHMANIA; MAMMAL CELL; MOUSE; NONHUMAN; PARASITE CLEARANCE; PARASITE CULTIVATION; PARASITE VIABILITY; PERITONEUM MACROPHAGE; PROMASTIGOTE; ANIMAL; DRUG EFFECTS; LEISHMANIASIS; MACROPHAGE; MITOCHONDRION;

LEISHMANIA AMAZONENSIS; MAMMALIA;

ANIMALS; ANTIPROTOZOAL AGENTS; ERYTHROCYTES; HUMANS; LEISHMANIA; LEISHMANIASIS; MACROPHAGES; MITOCHONDRIA; REACTIVE OXYGEN SPECIES; SALICYLATES; VANADIUM COMPOUNDS;

EID: 84929161667     PISSN: 0001706X     EISSN: 18736254     Source Type: Journal    
DOI: 10.1016/j.actatropica.2015.04.018     Document Type: Article

References (44)

1. Adriazola I.O., Evangelista do Amaral A., Amorim J.C., Correia B.L., Petkowicz C.L., Mercê A.L., Noleto G.R. Macrophage activation and leishmanicidal activity by galactomannan and its oxovanadium (IV/V) complex in vitro. J. Inorg. Biochem. 2014, 132:45-51.
2. Badmaev V., Prakash S., Majeed M. Vanadium: a review of its potential role in the fight against diabetes. J. Altern. Complement. Med. 1999, 5:273-291.
3. Benítez J., Becco L., Correia I., Leal S.M., Guiset H., Pessoa J.C., Lorenzo J., Tanco S., Escobar P., Moreno V., Garat B., Gambino D. Vanadium polypyridyl compounds as potential antiparasitic and antitumoral agents: new achievements. J. Inorg. Biochem. 2011, 105:303-312.
4. Benítez J., Cavalcanti de Queiroz A., Correia I., Alves M.A., Alexandre-Moreira M.S., Barreiro E.J., Lima L.M., Varela J., González M., Cerecetto H., Moreno V., Pessoa J.C., Gambino D. New oxidovanadium(IV) N-acylhydrazone complexes: promising antileishmanial and antitrypanosomal agents. Eur. J. Med. Chem. 2013, 62:20-27.
5. Bogdan C., Röllinghoff M. The immune response to Leishmania: mechanisms of parasite control and evasion. Int. J. Parasitol. 1998, 28:121-134.
6. Britta E.A., Barbosa Silva A.P., Ueda-Nakamura T., Dias-Filho B.P., Silva C.C., Sernaglia R.L., Nakamura C.V. Benzaldehyde thiosemicarbazone derived from limonene complexed with copper induced mitochondrial dysfunction in Leishmania amazonensis. PLoS One 2012, 7:e41440.
7. Carmo A.M.L., Silva F.M.C., Machado P.A., Fontes A.P.S., Pavan F.R., Leite C.Q.F., Leite S.R.A., Coimbra E.S., Da Silva A.D. Synthesis of 4-aminoquinoline analogues and their platinum(II) complexes as new antileishmanial and antitubercular agents. Biomed. Pharmacother. 2011, 65:204-209.
8. Costa G.S.M., Corbi P.P., Abbehausen C., Formiga A.L.B., Lustri W.R., Cuin A. Silver(I) and gold(I) complexes with penicillamine: synthesis, spectroscopic characterization and biological studies. Polyhedron 2012, 34:210-214.
9. Cuin A., Massabni A.C., Pereira G.A., Leite C.Q.F., Pavan F.R., Sesti-Costa R., Heinrich T.A., Costa-Neto C.M. 6-Mercaptopurine complexes with silver and gold ions: anti-tuberculosis and anti-cancer activities. Biomed. Pharmacother. 2011, 65:334-338.
10. de Souza N.B., Carmo A.M.L., Lagatta D.C., Alves M.J.M., Fontes A.P.S., Coimbra E.S., da Silva A.D., Abramo C. 4-Aminoquinoline analogues and its platinum (II) complexes as antimalarial agents. Biomed. Pharmacother. 2011, 65:313-316.
11. do Amaral A.E., Petkowicz C.L.O., Mercê A.L.R., Iacomini M., Martinez G.R., Rocha M.E.M., Cadena S.M.S.C., Noleto G.R. Leishmanicidal activity of polysaccharides and their oxovanadium(IV/V) complexes. Eur. J. Med. Chem. 2015, 90:732-741.
12. Fernández M., Becco L., Correia I., Benítez J., Piro O.E., Echeverria G.A., Medeiros A., Comini M., Lavaggi M.L., González M., Cerecetto H., Moreno V., Pessoa J.C., Garat B., Gambino D. Oxidovanadium(IV) and dioxidovanadium(V) complexes of tridentate salicylaldehyde semicarbazones: searching for prospective antitrypanosomal agents. J. Inorg. Biochem. 2013, 127:150-160.
13. Fonseca-Silva F., Inacio J.D.F., Canto-Cavalheiro M.M., Almeida-Amaral E.E. Reactive oxygen species production by quercetin causes the death of Leishmania amazonensis intracellular amastigotes. J. Nat. Prod. 2013, 76:1505-1508.
14. Fricker S.P., Mosi R.M., Cameron B.R., Baird I., Zhu Y., Anastassov V., Cox J., Doyle P.S., Hansell E., Lau G., Langille J., Olsen M., Qin L., Skerlj R., Wong R.S.Y., Santucci Z., McKerrow J.H. Metal compounds for the treatment of parasitic diseases. J. Inorg. Biochem. 2008, 102:1839-1845.
15. Gambino D. Advances and current perspectives in medicinal inorganic chemistry. Curr. Med. Chem. 2010, 17:3605.
16. Gambino D. Potentiality of vanadium compounds as anti-parasitic agents. Coord. Chem. Rev. 2011, 255:2193-2203.
17. Green L.C., Wagner D.A., Glogowski J., Skipper P.L., Wishnok J.S., Tannenbaum S.R. Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal. Biochem. 1982, 126:131-138.
18. Guilherme L.R., Massabni A.C., Cuin A., Oliveira L.A.A., Castellano E.E., Heinrich T.A., Costa-Neto C.M. Synthesis, characterization, crystal structure, and biological studies of vanadium complexes with glycolic acid. J. Coord. Chem. 2009, 62:1561-1571.
19. Machado P.A., Hilário F.F., Carvalho L.O., Silveira M.L.T., Alves R.B., Freitas R.P., Coimbra E.S. Effect of 3-alkylpyridine marine alkaloid analogues in Leishmania species related to American cutaneous leishmaniasis. Chem. Biol. Drug. Des. 2012, 80:745-751.
20. Matte C., Marquis J.F., Blanchette J., Gros P., Faure R., Posner B.I., Olivier M. Peroxovanadium-mediated protection against murine leishmaniasis: role of the modulation of nitric oxide. Eur. J. Immunol. 2000, 30:2555-2564.
21. McConville M.J., Naderer T. Metabolic pathways required for the intracellular survival of Leishmania. Annu. Rev. Microbiol. 2011, 65:543-561.
22. McGwire B.S., Satoskar A.R. Leishmaniasis: clinical syndromes and treatment. Q. J. Med. 2014, 107:7-14.
23. Menna-Barreto R.F.S., Goncalves R.L.S., Costa E.M., Silva R.S.F., Pinto A.V., Oliveira M.F., de Castro S.L. The effects on Trypanosoma cruzi of novel synthetic naphthoquinones are mediated by mitochondrial dysfunction. Free Radic. Biol. Med. 2009, 47:644-653.
24. Mesquita-Rodrigues C., Menna-Barreto R.F.S., Sabóia-Vahia L., Da-Silva S.A.G., de Souza E.M., Waghabi M.C., Cuervo P., De Jesus J.B. Cellular growth and mitochondrial ultrastructure of Leishmania (Viannia) braziliensis promastigotes are affected by the iron chelator 2,2-dipyridyl. PLoS Negl. Trop. Dis. 2013, 7:e2481.
25. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65:55-63.
26. Mota V.Z., de Carvalho G.S.G., Corbi P.P., Bergamini F.R.G., Formiga A.L.B., Diniz R., Freitas M.C.R., da Silva A.D., Cuin A. Crystal structure and theoretical studies of the keto-enol isomerism of N,N'-bis(salicylidene)-o-phenylenediamine (salophen). Spectrochim. Acta Mol. Biomol. 2012, 99:110-115.
27. Nathan C., Shiloh M.U. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc. Natl. Acad. Sci. 2000, 97:8841-8848.
28. Navarro M., Gabbiani C., Messori L., Gambino D. Metal-based drugs for malaria, trypanosomiasis and leishmaniasis: recent achievements and perspectives. Drug Discov. Today 2010, 15:1070-1078.
29. Ogunlaja A.S., Chidawanyika W., Antunes E., Fernandes M.A., Nyokong T., Torto N., Tshentu Z.R. Oxovanadium(IV)-catalysed oxidation of dibenzothiophene and 4,6 dimethyldibenzothiophene. Dalton Trans. 2012, 41:13908-13918.
30. Paiva I.L., de Carvalho G.S.G., da Silva A.D., Corbi P.P., Bergamini F.R.G., Formiga A.L.B., Diniz R., do Carmo W.R., Leite C.Q.F., Pavan F.R., Cuin A. Silver(I) complexes with symmetrical Schiff bases: synthesis, structural characterization, DFT studies and antimycobacterial assays. Polyhedron 2013, 62:104-109.
31. Patra P., Guha S.K., Maji A.K., Saha P., Ganguly S., Chakraborty A., Kundu P.K., Sarker S., Ray K. Efficacy of oral miltefosine in visceral leishmaniasis in rural West Bengal, India. Indian J. Pharmacol. 2012, 44:500-503.
32. Pereira G.A., Massabni A.C., Castellano E.E., Costa L.A.S., Leite C.Q.F., Pavan F.R., Cuin A. A broad study of two new promising antimycobacterial drugs: Ag(I) and Au(I) complexes with 2-(2-thienyl)benzothiazole. Polyhedron 2012, 38:291-296.
33. Ribeiro G.A., Cunha-Júnior E.F., Pinheiro R.O., da-Silva S.A.G., Canto-Cavalheiro M.M., da Silva A.J.M., Costa P.R.R., Netto C.D., Melo R.C.N., Almeida-Amaral E.E., Torres-Santos E.C. LQB-118, an orally active pterocarpanquinone, induces selective oxidative stress and apoptosis in Leishmania amazonensis. J. Antimicrob. Chemother. 2013, 68:789-799.
34. Rodrigues J.C.F., Godinho J.L.P., de Souza W. Biology of human pathogenic trypanosomatids: epidemiology, lifecycle and ultrastructure. Subcell. Biochem. 2014, 74:1-42.
35. Sardar A.H., Das S., Agnihorti S., Kumar M., Ghosh A.K., Abhishek K., Kumar A., Purkait B., Ansari M.Y., Das P. Spinigerin induces apoptotic like cell death in a caspase independent manner in Leishmania donovani. Exp. Parasitol. 2013, 135:715-725.
36. Singh B., Sundar S. Leishmaniasis: vaccine candidates and perspectives. Vaccine 2012, 30:3834-3842.
37. Sundar S., Jha T.K., Thakur C.P., Engel J., Sindermann H., Fischer C., Junge K., Bryceson A., Berman J. Oral miltefosine for Indian visceral Leishmaniasis. N. Engl. J. Med. 2002, 347:1739-1746.
38. Tavares J., Ouaissi M., Ouaissi A., Cordeiro-da-Silva A. Characterization of the anti-Leishmania effect induced by cisplatin, an anticancer drug. Acta Trop. 2007, 103:133-141.
39. Tempone A.G., Martins de Oliveira C., Berlinck R.G.S. Current approaches to discover marine antileishmanial natural products. Planta Med. 2011, 77:572-585.
40. Turner T.L., Nguyen V.H., McLauchlan C.C., Dymon Z., Dorsey B.M., Hooker J.D., Jones M.A. Inhibitory effects of decavanadate on several enzymes and Leishmania tarentolae in vitro. J. Inorg. Biochem. 2012, 108:96-104.
41. Vieites M., Smircich P., Guggeri L., Marchán E., Gómez-Barrio A., Navarro M., Garat B., Gambino D. Synthesis and characterization of a pyridine-2-thiol N-oxide gold(I) complex with potent antiproliferative effect against Trypanosoma cruzi and Leishmania sp. insight into its mechanism of action. J. Inorg. Biochem. 2009, 103:1300-1306.
42. Volpato H., Desoti V.C., Cogo J., Panice M.R., Sarragiotto M.H., Silva S.O., Ueda-Nakamura T., Nakamura C.V. The effects of N-butyl-1-(4-dimethylamino)phenyl-1,2,3,4-tetrahydro-b-carboline-3-carboxamide against Leishmania amazonensis are mediated by mitochondrial dysfunction. Evid. Based Complement. Alternat. Med. 2013, 2013:1-7.
43. Wang C., Qin X., Huang B., He F., Zeng C. Hemolysis of human erythrocytes induced by melamine-cyanurate complex. Biochem. Biophys. Res. Commun. 2010, 402:773-777.
44. World Health Organization (WHO) Leishmaniasis 2014, Available at: http://www.who.int/leishmaniasis/en/ (accessed 15.05.14.).